An article by Izabela Z. Schultz
(2013) in Psychological Injury and Law
discussed how the updated criteria for neurocognitive disorders may affect
forensic situations. Even with the focus
on forensic applications, many of the concerns she raises apply to any type of neuropsychological
evaluation (it should be noted that she also has positive things to say about
the changes; I am focusing on her criticisms here). Below I outline and respond to some of these
concerns.
In DSM-5, Major and Minor
Neurocognitive Disorder diagnoses depend on the presence (or absence) of both a
decline from previous functioning and inference with independence in activities
of daily living. The former consists of
both concern from an individual (i.e., client, clinician, or family member)
along with objective cognitive impairment, generally determined by neuropsychological
testing. Schultz cites problems with the
assessment of ADLs and with the use of neuropsychological tests in this
context. First, she claims that
psychologists may not have the skills to assess ADLs, given that this is
primarily the domain of occupational therapists. Although OTs specialize in ADL assessment, I’m
confident psychologists are also capable of assessing ADLs through interviews
and measures such as the Texas Functional Living Scale.
Schultz’s complaints about the
use of neuropsychological testing for the purposes of determining cognitive
impairment include:
1.
Arbitrary
cut-off values (in standard deviations from the mean) may result in
overdiagnosis of mild neurocognitive disorder and underdiagnosis of major
neurocognitive disorder.
2. Neuropsychological
measures may have psychometric problems and be prone to biases, errors, and
limitations with regard to certain populations who experience barriers to
assessment.
3.
Neuropsychologists
administer several tests, and there is no standard rule for how to determine
the overall level of impairment when test scores vary. In forensic settings, this could lead to consciously or unconsciously-biased diagnostic decision making.
4.
DSM-5
does not stress a multi-method approach involving qualitative methods in
addition to quantitative ones.
Related to Schultz’s first point
is another criticism: lack of a “moderate neurocognitive disorder”
diagnosis. Schultz is concerned that in
forensic settings, individuals who have serious functional problems may only be
diagnosed with the mild disorder, which could detrimentally affect case
outcomes. She raises a valid point when
she discusses the fact that DSM-5 acknowledges mild, moderate, and severe TBI
when there is no option to diagnose a moderate neurocognitive disorder. On the other hand, the cut-off values for
establishing cognitive impairment (1 or 2 standard deviations for minor and
major neurocognitive disorder respectively), are indeed somewhat arbitrary. Adding a moderate diagnosis would reduce the
range between the cut-off values, likely blurring the lines between the
disorders even more. Despite there being
no option to diagnose a moderate neurocognitive disorder, I am not overly
concerned about overdiagnosis of the mild form.
These diagnoses are not based solely on neuropsychological test scores –
they also take decline from previous functioning and independence in ADLs into
account. Therefore, someone will not be
diagnosed with a disorder based solely on scoring a standard deviation below
the mean on a neuropsychological measure.
Schultz’s second and fourth
points above appear to be less a problem with diagnostic criteria and more of
an issue of neuropsychologists’ ethics.
Neuropsychologists are ethically obligated to choose tests that are valid
for the purpose they are testing and for the individuals whom they are
testing. Therefore, the responsibility
is on the psychologist to consider the psychometric properties of each measure. Similarly, DSM-5’s lack of emphasis on
qualitative assessment methods is not a problem. Any competent psychologist knows that test
scores must be interpreted in light of other factors such as premorbid
functioning, clinical interview data, medical records, etc.
The third potential issue with
neuropsychological testing could certainly bring about some problems. It appears to be left up to individual
clinicians to determine how to judge overall severity when multiple measures
are administered with varying results.
For example, should an individual with one test that is two standard
deviations below the mean, with the rest being just one standard deviation
below the mean be diagnosed with major or minor neurocognitive disorder? A standard rule does seem to be indicated
here. At the least, neuropsychologists
should apply their own rule and use it consistently to avoid bias in forensic
situations.
Another point of contention to
the DSM-5 changes brought up in the article is the choice of specifiers for
individual sources of cognitive impairment. Schultz points out that rare diseases such as
prion disease are included, while other sources such as Multiple Sclerosis and
electrical injury are left out, relegated to the “due to another medical
condition” specifier. In forensic
settings, it seems that use of “due to another medical condition” specifier
shouldn’t be a problem, howeverm as the psychologist could discuss what that
medical condition is probably causing the problem (e.g., an electrical
injury). Admittedly, I’m not a forensic
psychologist, so maybe someone well-versed in that field could clear up this
question.
Finally, Schultz mentions that ADLs
are considered in the diagnostic criteria, but not other domains of impairment,
such as vocational or social impairment.
I agree that these should be part of the criteria, especially
considering that functional impairment can be independent of other indicators
such as neuropsychological test scores.
As an example, an individual with a 1 standard deviation decline in
cognitive functioning due to a TBI may experience more functional problems if
that individual has a cognitively demanding job as opposed to a job that
requires only manual labor.
Overall, I believe this category is
one of the few which improved with the new edition of the DSM. However, only time will tell how the updated
criteria will affect neuropsychological evaluations in forensic and other
settings.
American Psychiatric Association.
(2013). Diagnostic and statistical manual
of mental disorders (5th ed.). Arlington, VA: American
Psychiatric Publishing.
No comments:
Post a Comment